Guobang Pharma (SH:605507) Zheng Quan Zhi Xing·2025-08-21 16:36Core Viewpoint - The announcement details the transfer of shares from major shareholders of Guobang Pharmaceutical to Zhejiang State-owned Capital Operation Co., aiming to introduce a strategic investor to support the company's development in the pharmaceutical industry [1][2]. Summary by Sections 1. Overview of the Share Transfer Agreement - The share transfer involves three major shareholders: Weifang Shiqihui Equity Investment Partnership, Weifang Hongdehui Equity Investment Partnership, and Shaoxing Shiqingde Enterprise Management Partnership, transferring a total of 27,445,600 shares, representing 4.91% of the company's total share capital, to Zhejiang State-owned Capital Operation Co. at a price of 20.66 yuan per share, totaling approximately 567 million yuan [3][4]. 2. Strategic Cooperation Post-Transfer - After the share transfer, Zhejiang State-owned Capital Operation Co. plans to support Guobang Pharmaceutical's comprehensive development in the pharmaceutical sector, focusing on areas such as industry chain collaboration, new business cultivation, and capital operations [2][12]. 3. Shareholding Changes - Following the transfer, the shareholding structure will change, with Weifang Shiqihui holding 22,575,596 shares (4.04%), Weifang Hongdehui holding 4,441,550 shares (0.79%), and Shaoxing Shiqingde holding 393,875 shares (0.07%) [5][6]. 4. Compliance and Approval Process - The share transfer is subject to compliance confirmation by the Shanghai Stock Exchange and must be registered with the China Securities Depository and Clearing Corporation [6][13]. 5. Impact on Company Operations - The transfer will not change the controlling shareholder or actual controller of the company, ensuring stability in operations and decision-making processes [12][13]. The introduction of a strategic investor is expected to enhance the company's core competitiveness and resource synergy [12][13]. 6. Commitment from the New Shareholder - Zhejiang State-owned Capital Operation Co. has committed not to reduce its shareholding within six months following the transfer [2][14].